ArticleFrontiers in surgery2026
Total elbow arthroplasty for distal humeral fractures in the elderly population: good functional outcomes and a high implant survival rate can be expected after surgery.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Distal humeral fractures in elderly patients are difficult to treat due to poor bone quality and high complication rates. Total elbow arthroplasty (TEA) is an alternative for non-reconstructable fractures. This study aimed to evaluate long-term outcomes and implant survival of elderly subjects treated with linked TEA for acute distal humeral fractures. Methods: A retrospective study was conducted on data from patients who underwent TEA between January 2017 and December 2024 with fractures unsuitable for open reduction and internal fixation (ORIF). Clinical (range of motion, visual analogue scale, Mayo Elbow Performance Score, the Quick Disabilities of the Arm, Shoulder, and Hand score, and the American Shoulder and Elbow Surgeons score) and radiographic outcomes, complications, and implant survival were analysed. Results: Thirty-seven patients (mean age 80.4 ± 5.1 years) were followed for a mean of 107 ± 54 months. TEA permitted achievement of a good ROM (flexion 130 ± 8.16°; extension 19.8 ± 11.4°), and functional outcomes (VAS 3.3 ± 1.3, MEPS 83.5 ± 7.3, DASH 54 ± 4.4, ASES 78 ± 12.9) at the final follow-up. Revision rate was 11%, and 5-year implant survival was 94.2%. Comorbidities did not significantly influence clinical outcomes. Conclusion: TEA provides reliable long-term function and pain relief with acceptable complication rates in elderly patients with complex distal humeral fractures, supporting its use as a primary treatment in selected cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.